查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010042

麻醉剂市场：2026-2032年全球市场预测（按药物类型、给药途径、作用持续时间、应用和最终用户划分）

Anesthetic Drugs Market by Drug Type, Administration Route, Duration of Action, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，麻醉剂市场价值将达到 91.9 亿美元，到 2026 年将成长至 95.9 亿美元，到 2032 年将达到 125.3 亿美元，复合年增长率为 4.52%。

主要市场统计数据
基准年 2025 91.9亿美元
预计年份：2026年 95.9亿美元
预测年份 2032 125.3亿美元
复合年增长率 (%) 4.52%

麻醉剂的演进从根本上改变了医疗专业人员在医疗过程中保障病人舒适和安全的方式。从原始的植物萃取物到高度合成的化合物，该领域不断创新，旨在降低风险、提高疗效并扩大临床应用范围。这项进展凸显了药理学、外科技术和以患者为中心的护理之间密切的相互作用。

近年来，对动态和药物动力学的深入理解，促成了起效迅速、安全性更高的药物的研发。同时，微创手术技术的需求日益增长，使得能够促进患者快速恢復并减少术后併发症的麻醉剂变得至关重要。因此，製药公司、临床医生和监管机构之间的合作不断加强，为新一代麻醉解决方案的出现铺平了道路。

随着医学界不断追求优化患者疗效，麻醉剂仍然是这个领域的核心。全身麻醉剂和局部麻醉剂配方的创新有望应对从复杂麻醉剂手术到门诊疼痛管理等新的医疗挑战，而研究这些创新的动态变化对于参与整个医疗过程的相关人员至关重要。

透过突破性技术、实务和监管进步重新定义麻醉领域：改善病患预后

在技​​术突破和临床实践不断发展的推动下，麻醉剂领域正经历显着的变革。标靶给药系统和精准给药技术等前沿进展正在优化麻醉剂与神经系统的相互作用，从而最大限度地减少不利事件并提升患者舒适度。数位健康工具的整合进一步改善了手术全期监测，能够根据个体生理反应即时调整麻醉深度。

评估美国计划于 2025 年调整关税对全球麻醉剂供应链、资源可用性和成本结构的广泛影响。

美国于2025年推出的新关税结构对全球麻醉剂供应链产生了复杂的连锁反应。关键前驱物和辅料的进口关税推高了原物料成本，迫使製造商重新思考筹资策略，并在价格和可靠性之间寻求平衡。这些变化凸显了高度集中的供应链网路的脆弱性，并加速了采购管道多元化的趋势。

对麻醉剂市场进行了详细的細項分析，揭示了药物类型、给药途径、应用、给药持续时间和最终用户等关键观点。

要了解麻醉剂市场，需要详细掌握不同类型药物在临床实务中的作用机制。全身麻醉剂不断发展，旨在实现快速诱导和恢復，而局部麻醉剂则提供靶向神经阻断。在局部麻醉剂领域，酰胺类化合物的作用时间较长，而酯类化合物起效较快，但作用时间较短。根据手术的复杂程度和患者的风险因素，选择药物时需要考虑这些差异。

战略区域洞察，重点介绍美洲、欧洲、中东和非洲以及亚太地区的关键驱动因素、挑战和成长机会。

美洲地区依然受益于庞大的手术量、完善的法规结构以及对门诊护理日益增长的重视。对门诊手术中心的投资增加，推动了对速效、短效麻醉剂的需求，从而实现当日出院。此外，区域卫生部门正在推广以价值为导向的医疗模式，以缩短住院时间并最大限度地减少不利事件。

透过合作、通路建立和区域扩张，关键的企业策略和竞争措施正在塑造麻醉剂供应商的未来。

产业巨头正采取多种策略措施来强化其麻醉剂产品组合。大型製药企业正透过与专注于新型给药系统和前驱药物技术的生物技术公司建立有针对性的合作关係来丰富其产品线。这些合作旨在透过提高安全性、拓展临床适应症来使产品脱颖而出。

为产业领导者提供切实可行的策略建议，以增强麻醉剂。

麻醉剂产业的领导企业应考虑建立跨产业合作伙伴关係，以加速创新并分担研发风险。与Start-Ups和学术机构合作，能够获得新型分子和先进的製剂技术；而共同开发契约则有助于简化商业化流程。同时，透过增设区域生产基地实现製造地多元化，将增强供应链抵御贸易中断的能力。

采用稳健的调查方法，结合定性和定量方法，为麻醉剂行业的趋势提供准确、实用的见解。

本研究采用综合混合方法框架，以确保研究的严谨性和可靠性。研究人员对麻醉医师、采购负责人和监管专家进行了结构化访谈，收集了第一手定性信息，从而获得了关于药物选择、临床偏好和新挑战的直接观点。这些访谈结果与同行评审期刊、临床试验註册资讯和公开的监管申报资料进行了交叉比对，以检验技术性发现。

一项综合分析，旨在探讨在不断发展的麻醉剂产业中，如何应对新兴趋势、风险和机会的关键见解和挑战。

本分析整合了影响麻醉剂市场的关键趋势、挑战和策略问题。从贸易政策变化导致的供应链脆弱性，到精准给药技术的兴起，相关人员必须应对日益复杂的市场环境。关键的细分洞察凸显了药物类型、给药途径、给药持续时间、应用以及最终用户背景对于有效建构产品系列的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按药物类型分類的麻醉剂市场

  • 全身麻醉剂
  • 局部麻醉剂
    • 酰胺型
    • 酯类

第九章：依给药途径分類的麻醉剂市场

  • 吸入
  • 肌肉内部
  • 静脉

第十章：依作用持续时间分類的麻醉剂市场

  • 长效型
  • 短效

第十一章：麻醉剂市场：依应用领域划分

  • 牙科治疗
    • 外科手术
    • 预防
  • 产科
  • 疼痛管理
    • 急性疼痛
    • 慢性疼痛
  • 外科手术
    • 心臟外科手术
    • 一般外科
    • 神经外科
    • 整形外科手术
    • 整形外科

第十二章：麻醉剂市场：依最终用户划分

  • 门诊手术中心
  • 医院和诊所

第十三章：麻醉剂市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：麻醉剂市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：麻醉剂市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国麻醉剂市场

第十七章：中国麻醉剂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Apotex Inc.
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • B. Braun SE
  • Baxter International Inc.
  • Boehringer Ingelheim International GmbH
  • Claris Lifesciences Limited
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Mylan NV
  • Novartis AG
  • Pacira Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Piramal Enterprises LTD
  • Septodont Healthcare India Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc.
  • Weefsel Pharma
Product Code: MRR-434CCDA05121

The Anesthetic Drugs Market was valued at USD 9.19 billion in 2025 and is projected to grow to USD 9.59 billion in 2026, with a CAGR of 4.52%, reaching USD 12.53 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.19 billion
Estimated Year [2026] USD 9.59 billion
Forecast Year [2032] USD 12.53 billion
CAGR (%) 4.52%

The evolution of anesthetic drugs has fundamentally transformed the way healthcare professionals manage patient comfort and safety during medical procedures. From rudimentary plant extracts to sophisticated synthetic compounds, the field has undergone relentless innovation to reduce risk, improve efficacy, and broaden the scope of clinical applications. This journey underscores the vital intersection between pharmacology, surgical technique, and patient-centered care.

In recent years, a deeper understanding of pharmacodynamics and pharmacokinetics has driven the development of agents with faster onset times and enhanced safety profiles. At the same time, rising demand for minimally invasive surgical techniques has placed a premium on anesthetic drugs that enable rapid recovery and reduce postoperative complications. Consequently, collaboration across drug developers, clinicians, and regulatory bodies has accelerated, paving the way for a new generation of anesthetic solutions.

As the medical community continues to pursue optimized patient outcomes, the role of anesthetic drugs remains central. Innovations in both general and local anesthetic formulations are poised to address emerging healthcare challenges, from complex surgical interventions to outpatient pain management, making the study of their dynamics indispensable for stakeholders across the continuum of care.

Emerging Transformations Redefining the Anesthetic Landscape Through Breakthrough Technologies Practices and Regulatory Advancements Enhancing Patient Outcomes

The anesthetic drug sector is experiencing remarkable shifts propelled by technological breakthroughs and evolving clinical practices. Cutting-edge advances such as targeted delivery systems and precision dosing technologies are refining how anesthetics interact with the nervous system, thereby minimizing adverse events and optimizing patient comfort. Integrating digital health tools has further improved perioperative monitoring, allowing real-time adjustments to anesthesia depth based on individual physiological responses.

Regulatory landscapes are also playing a transformative role. Newly implemented guidelines emphasize rigorous safety assessments, streamlined approval pathways, and post-market surveillance tailored to address emerging risks such as rare allergic reactions or potential neurotoxicity. This regulatory momentum, coupled with heightened patient awareness around procedural safety, is encouraging pharmaceutical companies to invest heavily in differentiated products that demonstrate clear clinical advantages.

Transitioning from traditional formulations to next-generation molecules requires robust collaboration among academic research centers, biotech innovators, and established pharmaceutical firms. The convergence of artificial intelligence for drug discovery, nanotechnology for targeted delivery, and enhanced formulation science is setting the stage for anesthetic agents that adapt dynamically to procedural demands, ultimately redefining standards of care.

Assessing the Far Reaching Effects of United States Tariff Adjustments Set for 2025 on Global Anesthetic Drug Supply Chains Resource Availability and Cost Structures

The introduction of new tariff structures by the United States in 2025 has led to complex reverberations throughout the global anesthetic drug supply chain. Import duties on key precursors and excipients have heightened raw material costs, prompting manufacturers to reevaluate sourcing strategies and prioritize reliability alongside price. These changes have underscored the vulnerability of highly centralized supply networks, catalyzing a shift towards diversified procurement channels.

Consequently, several major producers have begun to establish regional production hubs to mitigate cost volatility and buffer against unexpected trade policy shifts. While this move toward nearshoring offers greater supply security, it also demands significant capital investment and compliance with local regulatory frameworks. As a result, stakeholders are collaborating with logistics specialists and regulatory experts to ensure seamless cross-border workflows that maintain product quality and consistency.

Moreover, healthcare providers are adapting by optimizing inventory management systems and forging strategic partnerships with suppliers to secure prioritized access. In parallel, ongoing dialogue between industry associations and policymakers is seeking to balance national economic objectives with uninterrupted patient care. Thus, the accelerated tariff environment has become a catalyst for both operational resilience and innovative supply chain redesign.

In Depth Segmentation Insights Unveiling Critical Perspectives on Drug Types Routes Applications Durations and End Users in the Anesthetic Market

Understanding the anesthetic drugs market requires a nuanced appreciation of how diverse drug types perform across clinical contexts. General anesthetics have evolved to provide rapid induction and recovery, while local anesthetics offer targeted nerve blockade. Within the local segment, amide-based compounds deliver longer durations of action, whereas ester-based agents offer rapid onset but shorter persistence. These distinctions inform drug selection depending on procedural complexity and patient risk factors.

Administration route further refines therapeutic approaches. Inhalation anesthetics allow precise titration during extensive surgical interventions, whereas intramuscular formulations serve as practical options in settings lacking intravenous access. Intravenous delivery remains the gold standard for rapid sedation and intraoperative control. Clinicians weigh onset speed against procedural requirements to match route selection with clinical objectives.

Duration of action also influences drug utilization. Long-acting agents support extended surgical procedures and postoperative analgesia, while short-acting compounds facilitate brief interventions and enable swift patient turnover. This temporal dimension of anesthetic planning is critical for balancing efficacy, safety, and resource allocation.

Applications span a wide spectrum of medical specialties. In dental care, injectable anesthetics enable both operative and preventive treatments, ensuring patient comfort during routine procedures. Obstetric anesthesia requires careful dosing strategies to balance maternal analgesia with fetal safety. Pain management leverages acute formulations to address postoperative discomfort and chronic options to alleviate long-term conditions. Surgical procedures demand specialized agents for cardiac surgery, general surgery, neurosurgery, orthopedic operations, and plastic surgery, each with unique anesthetic requirements.

Finally, the end users of anesthetic drugs operate in distinct environments. Ambulatory surgical centers emphasize rapid patient throughput and minimal recovery times, while hospitals and clinics require versatile anesthetic portfolios to cover diverse procedural needs. Together, these segmentation lenses reveal critical trade-offs and optimization pathways in formulating, administering, and delivering anesthetics effectively.

Strategic Regional Insights Highlighting Key Drivers Challenges and Growth Opportunities Across Americas EMEA and Asia Pacific Territories

The Americas region continues to be driven by extensive surgical volumes, well-established regulatory frameworks, and a growing focus on ambulatory care. Heightened investment in outpatient surgical centers is fostering demand for rapid-onset, short-acting anesthetics that support same-day discharge. In addition, regional health authorities are promoting value-based care models that incentivize reduced hospital stays and minimized adverse events.

Within Europe, the Middle East and Africa, regulatory harmonization initiatives such as centralized approval processes have facilitated the entry of innovative anesthetic compounds across multiple jurisdictions. Yet market maturity varies widely, with advanced economies prioritizing next-generation agents and emerging markets focusing on cost-effective generics. In parallel, infrastructure development projects in certain Middle Eastern and African nations are expanding surgical capacity, creating fresh opportunities for anesthetic providers.

The Asia-Pacific region is characterized by rapid modernization of healthcare infrastructure and growing surgical caseloads. Emerging economies in Southeast Asia and South Asia are witnessing increased access to elective procedures, fueling demand for both general and local anesthetics. Moreover, investments in domestic manufacturing capabilities are reducing reliance on imports and positioning local players to compete in regional export markets. As a result, the Asia-Pacific landscape presents a dynamic interplay of innovation, capacity building, and escalating patient demand.

Key Corporate Strategies and Competitive Moves Shaping the Future of Anesthetic Drug Suppliers Through Partnerships Pipelines and Geographic Expansion

Major industry players are pursuing a variety of strategic moves to strengthen their anesthetic drug portfolios. Leading pharmaceutical companies are deepening their pipelines through targeted partnerships with biotechnology firms specializing in novel delivery systems and prodrug technologies. Such collaborations aim to differentiate products by enhancing safety profiles and expanding clinical indications.

In parallel, several organizations are investing in regional expansion, establishing manufacturing and distribution centers closer to key customer bases. This geographic diversification not only reduces lead times but also supports compliance with local regulatory requirements. These efforts are often complemented by acquisitions of smaller niche players, enabling larger firms to incorporate specialized expertise and fill portfolio gaps rapidly.

Research and development remains a critical focus area, with emphasis on integrating digital health platforms for anesthesia monitoring and management. By embedding smart monitoring technologies and leveraging data analytics, companies are seeking to provide comprehensive perioperative solutions that go beyond conventional drug delivery. These initiatives are aligned with broader trends toward personalized medicine and value-based care.

Actionable Strategic Recommendations for Industry Leaders to Strengthen Research Development Supply Chain Agility and Market Differentiation in Anesthetics

Leaders in the anesthetic drug industry should consider forging cross-sector alliances to accelerate innovation and share development risks. Engaging with startups and academic institutions can provide access to novel molecules and advanced formulation techniques, while co-development agreements can streamline commercialization pathways. Simultaneously, diversifying manufacturing footprints by incorporating regional production hubs will enhance supply chain resilience against trade disruptions.

Adopting digital platforms for anesthesia management presents another opportunity. Integrating real-time monitoring tools and predictive analytics into clinical workflows can optimize agent selection, dosage calibration, and patient recovery protocols. This technological convergence will strengthen value propositions for providers and improve overall patient safety.

Furthermore, tailoring regional strategies to local regulatory and clinical environments is essential. In mature markets, emphasizing differentiated, high-value products that support out-patient procedures can yield competitive advantage, while in emerging markets, cost-effective portfolios and flexible distribution partnerships will drive adoption. By adopting a dual approach that balances innovation with affordability, companies can capture diverse market segments effectively.

Robust Research Methodology Combining Qualitative and Quantitative Approaches to Deliver Accurate and Actionable Insights into the Anesthetic Drug Landscape

This research draws on a comprehensive mixed-methodology framework to ensure rigor and reliability. Primary qualitative insights were gathered through structured interviews with anesthesiologists, procurement specialists, and regulatory experts, providing firsthand perspectives on drug selection, clinical preferences, and emerging challenges. These insights were triangulated with data from peer-reviewed journals, clinical trial registries, and publicly available regulatory filings to validate technical findings.

Quantitative assessments incorporated detailed analysis of trade data, ingredient sourcing patterns, and facility output to map supply chain dynamics. Advanced statistical techniques were employed to detect trends and identify key drivers of change. In addition, a panel of independent industry veterans reviewed all findings to ensure objectivity and contextual accuracy.

Throughout the study, robust data quality protocols were applied, including source verification, consistency checks, and iterative feedback loops with subject matter experts. This multilayered approach delivers a cohesive picture of the anesthetic drug landscape, equipping decision-makers with actionable insights grounded in empirical evidence and expert validation.

Conclusive Analysis Synthesizing Key Findings and Imperatives to Navigate Emerging Trends Risks and Opportunities in the Evolving Anesthetic Drug Sector

This analysis synthesizes the critical trends, challenges, and strategic imperatives shaping the anesthetic drugs arena. From materializing supply chain vulnerabilities under shifting trade policies to the advent of precision administration technologies, stakeholders must navigate an increasingly complex environment. Key segmentation insights underscore the importance of drug type, administration route, duration, application, and end-user context in tailoring product portfolios effectively.

Regional dynamics further emphasize the need for adaptive strategies, balancing innovation and cost efficiency across diverse healthcare systems. Corporate maneuvers, including alliances, acquisitions, and digital integrations, highlight competitive priorities in securing long-term growth. By leveraging a robust mixed-methodology framework, this report delivers validated insights to guide strategic decision-making.

Moving forward, collaboration across the value chain-from raw material suppliers to end-user institutions-will be instrumental in driving enhanced patient outcomes while safeguarding operational resilience. This comprehensive conclusion invites stakeholders to refine their approach in line with emerging technological, regulatory, and market forces, laying a foundation for sustained leadership in the evolving anesthetic drug sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anesthetic Drugs Market, by Drug Type

  • 8.1. General Anesthetics
  • 8.2. Local Anesthetics
    • 8.2.1. Amides
    • 8.2.2. Esters

9. Anesthetic Drugs Market, by Administration Route

  • 9.1. Inhalation
  • 9.2. Intramuscular
  • 9.3. Intravenous

10. Anesthetic Drugs Market, by Duration of Action

  • 10.1. Long-Acting
  • 10.2. Short-Acting

11. Anesthetic Drugs Market, by Application

  • 11.1. Dental Procedures
    • 11.1.1. Operative
    • 11.1.2. Preventive
  • 11.2. Obstetrics
  • 11.3. Pain Management
    • 11.3.1. Acute Pain
    • 11.3.2. Chronic Pain
  • 11.4. Surgical Procedures
    • 11.4.1. Cardiac Surgery
    • 11.4.2. General Surgery
    • 11.4.3. Neuro Surgery
    • 11.4.4. Orthopedic Surgery
    • 11.4.5. Plastic Surgery

12. Anesthetic Drugs Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics

13. Anesthetic Drugs Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Anesthetic Drugs Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Anesthetic Drugs Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Anesthetic Drugs Market

17. China Anesthetic Drugs Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. Apotex Inc.
  • 18.7. Aspen Pharmacare Holdings Limited
  • 18.8. AstraZeneca PLC
  • 18.9. B. Braun SE
  • 18.10. Baxter International Inc.
  • 18.11. Boehringer Ingelheim International GmbH
  • 18.12. Claris Lifesciences Limited
  • 18.13. Eisai Co. Ltd.
  • 18.14. F. Hoffmann-La Roche Ltd.
  • 18.15. Fresenius SE & Co. KGaA
  • 18.16. Hikma Pharmaceuticals PLC
  • 18.17. Mylan N.V.
  • 18.18. Novartis AG
  • 18.19. Pacira Pharmaceuticals, Inc.
  • 18.20. Pfizer Inc.
  • 18.21. Piramal Enterprises LTD
  • 18.22. Septodont Healthcare India Pvt. Ltd.
  • 18.23. Sun Pharmaceutical Industries Ltd.
  • 18.24. Teva Pharmaceutical Industries Limited
  • 18.25. Viatris Inc.
  • 18.26. Weefsel Pharma

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ESTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ESTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ESTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LONG-ACTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LONG-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SHORT-ACTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SHORT-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OPERATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OPERATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OPERATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PREVENTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PREVENTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PREVENTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OBSTETRICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OBSTETRICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY OBSTETRICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY NEURO SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY NEURO SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY NEURO SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. GCC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. GCC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 178. GCC ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 182. GCC ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 183. GCC ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 184. GCC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. G7 ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 208. G7 ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. G7 ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 212. G7 ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 213. G7 ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 214. G7 ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. NATO ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. NATO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NATO ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 220. NATO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. NATO ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 222. NATO ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. NATO ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 224. NATO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA ANESTHETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHETICS, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA ANESTHETIC DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DURATION OF ACTION, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DENTAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA ANESTHETIC DRUGS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA ANESTHETIC DRUGS MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)